IRB Approval. If required, Principal Investigator will ensure that the Study is approved by and subject to continuing oversight by an appropriate Institutional Review Board (IRB). Institution will provide CMT with documentation of both the initial IRB approval and annual renewals of that approval. Institution will notify CMT promptly of any withdrawal or suspension of IRB approval during the term of this Agreement.
Appears in 2 contracts
Sources: Clinical Trial Agreement (Creative Medical Technology Holdings, Inc.), Clinical Trial Agreement (Creative Medical Technology Holdings, Inc.)